Proteins

Items 31-40 of 936

per page
Set Descending Direction
  1. ANGPTL3 (mouse) (rec.)
    AG-40A-0082
    AG-40A-0082-C01010 µg
    CHF 190.00
    AG-40A-0082-C05050 µg
    CHF 380.00
  2. ANGPTL4 (fibrinogen-like domain) (human) (rec.)
    AG-40A-0070
    AG-40A-0070-C01010 µg
    CHF 290.00
    AG-40A-0070-C05050 µg
    CHF 830.00
  3. ANGPTL4 (mouse) (rec.)
    AG-40A-0075
    AG-40A-0075-C01010 µg
    CHF 190.00
    AG-40A-0075-C05050 µg
    CHF 380.00
    ERK phosphorylation induced by hANGPTL4 in THP-1 cells.
THP-1 monocyte cells were serum starved for 16hr and then stimulated with ANGPTL4 (mouse) (rec.) (Prod. No. AG-40A-0075) (500ng/ml) for 1, 2 and 3 hrs, respectively. Antibodies against pERK1/2
  4. ANGPTL7 (human) (rec.)
    AG-40A-0060
    AG-40A-0060-C01010 µg
    CHF 265.00
    AG-40A-0060-C05050 µg
    CHF 790.00
    ERK phosphorylation induced by hANGPTL7 in THP-1 cells.
THP-1 monocyte cells were serum starved for 16hr and then stimulated with ANGPTL7 (human) (rec.) (Prod. No. AG-40A-0060) (500ng/ml) for 1, 2 and 3 hrs, respectively. Antibodies against pERK1/2
  5. Annexin V (human) (rec.)
    AG-40B-0005
    AG-40B-0005-C100100 µg
    CHF 205.00
  6. Annexin V (human) (rec.) (ATTO 488)
    AG-40B-0005TD
    AG-40B-0005TD-T100100 tests
    CHF 190.00
  7. Annexin V (human) (rec.) (ATTO 647N)
    AG-40B-0005TS
    AG-40B-0005TS-T100100 tests
    CHF 190.00
  8. Annexin V (human) (rec.) (FITC)
    AG-40B-0005F
    AG-40B-0005F-T02020 tests
    CHF 115.00
    AG-40B-0005F-T100100 tests
    CHF 235.00
    AG-40B-0005F-T300300 tests
    CHF 350.00
  9. APRIL (human) (H98) (multimeric) (rec.)
    AG-40B-0088
    AG-40B-0088-C01010 µg
    CHF 380.00
    AG-40B-0088-30103 x 10 µg
    CHF 760.00
    AG-40B-0088-C100100 µg
    CHF 1'800.00
  10. APRIL (human) (multimeric) (rec.)
    AG-40B-0017
    AG-40B-0017-C01010 µg
    CHF 360.00
    AG-40B-0017-30103 x 10 µg
    CHF 720.00

Items 31-40 of 936

per page
Set Descending Direction
© 2017 Adipogen Life Sciences. Pictures: © 2012 Martin Oeggerli. All Rights Reserved.